The expression of the main four factors (hENT1, dCK, RRM1 and RRM2) involved in gemcitabine transport and metabolism was also shown to correlate with acquired resistance to gemcitabine in pancreatic cancer cells [35]. The gene discussed is RRM1; the disease is familial pancreatic carcinoma.